Matreya/N-Dotriacontanoyl-D-erythro-sphingosine/2048/5 mg
Catalog #:2048Scientific Name:N-Dotriacontanoyl-D-erythro-sphingosineCommon Name:N-C32:0-D-erythro-CeramideEmpirical Formula:C50H99NO3SDSView Safety Data SheetData Sheet:View Data SheetFormula Weight:762Unit:5 mgSolvent:noneSource:syntheticPurity:98+%Analytical Methods:TLC, GC, identity confirmed by MSSolubility:hot methanol, hot ethanol, hot DMSO, chloroform/methanol, 2:1Physical Appearance:solidStorage:-20°CDry Ice:NoHazardous:NoLiterature References:1. J. M. Hauser, B. M. Buehrer, and R. M. Bell \"Role of ceramide in mitogenesis induced by exogenous sphingoid bases.” Journal of Biological Chemistry Vol. 269 pp. 6803, 19942. N. S. Radin, \"Killing tumours by ceramide-induced apoptosis: a critique of available drugs” Biochemical Journal, Vol. 371 pp. 243-256, 20033. N. S. Radin, \"Designing anticancer drugs via the achilles heel: ceramide, allylic ketones, and mitochondria” Bioorganic and Medicinal Chemistry, Vol. 11(10) pp. 2123-2142, 20034. R. Sandhoff \"Very long chain sphingolipids: Tissue expression, function and synthesis” FEBS Letters Vol. 584(9) pp. 1907-1913, 20105. W. Li \"Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice” Int J Biol Sci, Vol. 3 pp. 120-128, 2007